Economic value added and market value added: a study of pharmaceutical industry
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
- T 658.155.4 K12E
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
![]() |
Mohinder Singh Randhawa Library | T 658.155.4 K12E (Browse shelf(Opens below)) | Not for loan | 249952 | ||
![]() |
Mohinder Singh Randhawa Library | T 658.155.4 K12E (Browse shelf(Opens below)) | Not for loan | 249953 |
Browsing Mohinder Singh Randhawa Library shelves Close shelf browser (Hides shelf browser)
The researcher has tried to find out the relationship between Economic Value Added (EVA) and Market Value Added (MV A) prevalent in the Pharmaceutical industry. The EVA and MV A of 25 companies were calculated for the years 2003 to 2007. These new measure
There are no comments on this title.
Log in to your account to post a comment.